Santiago Lozano

Santiago Lozano has extensive work experience in various positions. Santiago started their career as a Business Analyst at Clave Mayor SA SGEIC in 2005 and later became an Investment Manager from 2009 to 2014. Santiago also served as a Fund Manager for several funds, including UN I+D+i Tech Transfer f.c.r., Navarra Tech Transfer f.c.r., and Ronda TIC F.C.R. at Clave Mayor SA SGEIC. Santiago Lozano was also a Member of the Board of Directors in multiple companies invested by Clave Mayor Funds.

In addition to their roles at Clave Mayor SA SGEIC, Santiago Lozano has worked as an External Evaluator for EIT Health since 2020 and an Expert Evaluator for Eureka Network since 2019. Santiago has also served as an External Collaborator for MSc Biomedical Engineering at the University of Navarra in 2018.

More recently, Santiago Lozano has held positions on the Board of Directors for MainRail, Predictheon, UPTECH SENSING, Telum Therapeutics, Polimerbio, and Genbioma SL, starting from 2020 to 2021.

Overall, Santiago Lozano has a diverse range of experience in fund management, investment roles, board membership, evaluation, and collaboration in the biomedical engineering field.

Santiago Lozano's education history includes a Master's degree in Dirección Financiera from ESIC Business & Marketing School, which they obtained from 2004 to 2005. Prior to that, they attended the University of Navarra from 1991 to 1996, where they obtained a Licenciado degree in Económicas. Santiago also engaged in a research program in quantitative economics, known as Suficiencia Investigadora in Spain, at the Universidad Nacional de Educación a Distancia (UNED) from 2000 to 2002. The specific field of study for this research program is not mentioned.